123 related articles for article (PubMed ID: 12845720)
1. Preliminary study of the in vitro growth inhibition of human bladder cancer cell line BIU-87 by arsenic trioxide.
Tong Q; Zeng F; Zhu Z; Lu G
J Tongji Med Univ; 2000; 20(2):112-5. PubMed ID: 12845720
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87.
Tong Q; Zeng F; Zheng L; Zhao J; Lu G
Chin Med J (Engl); 2001 Apr; 114(4):402-6. PubMed ID: 11780464
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
4. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
Huang SG; Kong BH; Ma YY; Jiang S
Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
[TBL] [Abstract][Full Text] [Related]
5. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
[TBL] [Abstract][Full Text] [Related]
6. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
9. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
Chen GQ; Zhu J; Shi XG; Ni JH; Zhong HJ; Si GY; Jin XL; Tang W; Li XS; Xong SM; Shen ZX; Sun GL; Ma J; Zhang P; Zhang TD; Gazin C; Naoe T; Chen SJ; Wang ZY; Chen Z
Blood; 1996 Aug; 88(3):1052-61. PubMed ID: 8704214
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Wang ZG; Rivi R; Delva L; König A; Scheinberg DA; Gambacorti-Passerini C; Gabrilove JL; Warrell RP; Pandolfi PP
Blood; 1998 Sep; 92(5):1497-504. PubMed ID: 9716575
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S
Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2.
Ai Z; Lu W; Qin X
Biochem Biophys Res Commun; 2006 Sep; 348(3):1075-81. PubMed ID: 16904648
[TBL] [Abstract][Full Text] [Related]
15. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
Sun Y; Wang C; Wang L; Dai Z; Yang K
Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
[TBL] [Abstract][Full Text] [Related]
17. [An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
Liu L; Qin S; Chen H; Wang J; Chen H; Ma J; Liu W
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):367-9. PubMed ID: 11135700
[TBL] [Abstract][Full Text] [Related]
18. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
Shao QS; Ye ZY; Ling ZQ; Ke JJ
World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
